Markelewicz RJ Jr, Lorenzen WA, Shusterman S, Grant FD, Fahey FH, Treves ST. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy. Clin Nucl Med. 2013; 38(8):604-7. doi: 10.1097/RLU.0b013e31829af3c8.
Kono Y, Miyamoto Y, Oohashi S, Fukushi M. Radiation exposure to general public after permanent brachytherapy for prostate cancer. Radiat Prot Dosimetry. 2011 146(1-3):229-30.
Castiglia F, Giardina M, Tomarchio E. Risk analysis using fuzzy set theory of the accidental exposure of medical staff during brachytherapy procedures. J Radiol Prot. 2010 30(1):49-62.
So WK, Chui YY. Women's experience of internal radiation treatment for uterine cervical cancer. J Adv Nurs. 2007 60(2):154-61.
Cattani F, Vavassori A, Polo A, Rondi E, Cambria R, Orecchia R, Tosi G. Radiation exposure after permanent prostate brachytherapy. Radiother Oncol. 2006 79(1):65-9.
Kirisits C, Hefner A, Wexberg P, Pokrajac B, Glogar D, Pötter R, Georg D. Estimation of doses to personnel and patients during endovascular brachytherapy applications. Radiat Prot Dosimetry. 2004;108(3):237-45.
Clapis MJ, Mamede MV. Experiences of women in cesium brachytherapy. Rev Lat Am Enfermagem. 1996; 4(2):131-46.